Strategic Diagnostics Inc. Announces Successful Expansion Of Proprietary Antibody Technology Into The Japanese Life Science Industry Through Partnership With Oriental Yeast Company

NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) - today announced that its partnership with the Oriental Yeast Company is meeting commercialization targets for its Genomic Antibodies™ service offering within the Japanese Life Science industry.